Association between CAG repeat length in the PPP2R2B gene and Alzheimer disease in the Japanese population

Neuroscience Letters

Volumn 487, Issue 3, 2011, Pages 354-357

  Kimura, Ryo ^a   Morihara, Takashi ^b   Kudo, Takashi ^b   Kamino, Kouzin ^c   Takeda, Masatoshi ^b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Alzheimer disease; CAG repeat; PPP2R2B

Indexed keywords

APOLIPOPROTEIN E4; DNA FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CAG REPEAT; CONTROLLED STUDY; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PPP2R2B GENE; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN PHOSPHATASE 2; REPETITIVE SEQUENCES, NUCLEIC ACID; TRINUCLEOTIDE REPEATS;

EID: 78650519753     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.10.055     Document Type: Article

References (31)

1. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
2. Brusco A., Cagnoli C., Franco A., Dragone E., Nardacchione A., Grosso E., Mortara P., Mutani R., Migone N., Orsi L. Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1-3, 6 and 7 CAG expansions. J. Neurol. 2002, 249:923-929.
3. Chen C.M., Hou Y.T., Liu J.Y., Wu Y.R., Lin C.H., Fung H.C., Hsu W.C., Hsu Y., Lee S.H., Hsieh-Li H.M., Su M.T., Chen S.T., Lane H.Y., Lee-Chen G.J. PPP2R2B CAG repeat length in the Han Chinese in Taiwan: association analyses in neurological and psychiatric disorders and potential functional implications. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:124-129.
4. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
5. Fujigasaki H., Verma I.C., Camuzat A., Margolis R.L., Zander C., Lebre A.S., Jamot L., Saxena R., Anand I., Holmes S.E., Ross C.A., Durr A., Brice A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann. Neurol. 2001, 49:117-121.
6. Gong C.X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience 1994, 61:765-772.
7. Gong C.X., Lidsky T., Wegiel J., Zuck L., Grundke-Iqbal I., Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J. Biol. Chem. 2000, 275:5535-5544.
8. Gong C.X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J. Neurochem. 1995, 65:732-738.
9. Harris F.M., Brecht W.J., Xu Q., Mahley R.W., Huang Y. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J. Biol. Chem. 2004, 279:44795-44801.
10. Holmes S.E., Hearn E.O., Ross C.A., Margolis R.L. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res. Bull. 2001, 56:397-403.
11. Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A., Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G., Sherr M., Sumner A.J., Sharp A.H., Ananth U., Seltzer W.K., Boss M.A., Vieria-Saecker A.M., Epplen J.T., Riess O., Ross C.A., Margolis R.L. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat. Genet. 1999, 23:391-392.
12. Iqbal K., Alonso Adel C., Chen S., Chohan M.O., El-Akkad E., Gong C.X., Khatoon S., Li B., Liu F., Rahman A., Tanimukai H., Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta 2005, 1739:198-210.
13. Iqbal K., Liu F., Gong C.X., Alonso Adel C., Grundke-Iqbal I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol. 2009, 118:53-69.
14. Kim J., Basak J.M., Holtzman D.M. The role of apolipoprotein E in Alzheimer's disease. Neuron 2009, 63:287-303.
15. Kimura R., Kamino K., Yamamoto M., Nuripa A., Kida T., Kazui H., Hashimoto R., Tanaka T., Kudo T., Yamagata H., Tabara Y., Miki T., Akatsu H., Kosaka K., Funakoshi E., Nishitomi K., Sakaguchi G., Kato A., Hattori H., Uema T., Takeda M. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease. Hum. Mol. Genet. 2007, 16:15-23.
16. Korade Z, Kenworthy A.K. Lipid rafts, cholesterol, and the brain. Neuropharmacology 2008, 55:1265-1273.
17. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
18. Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 2005, 22:1942-1950.
19. Mahley R.W., Nathan B.P., Pitas R.E., Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1996, 777:139-145.
20. Manto M.U The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 2005, 4:2-6.
21. Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J., Merlevede W., Hofsteenge J., Hemmings B.A. Structure of the 55-kDa regulatory subunit of protein phosphatase 2A: evidence for a neuronal-specific isoform. Biochemistry 1991, 30:3589-3597.
22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
23. O'Hearn E., Holmes S.E., Calvert P.C., Ross C.A., Margolis R.L. SCA-12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 2001, 56:299-303.
24. Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu. Rev. Med. 1996, 47:387-400.
25. Ross C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002, 35:819-822.
26. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
27. Srivastava A.K., Choudhry S., Gopinath M.S., Roy S., Tripathi M., Brahmachari S.K., Jain S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann. Neurol. 2001, 50:796-800.
28. Sulek A., Hoffman-Zacharska D., Bednarska-Makaruk M., Szirkowiec W., Zaremba J. Polymorphism of trinucleotide repeats in non-translated regions of SCA8 and SCA12 genes: allele distribution in a Polish control group. J. Appl. Genet. 2004, 45:101-105.
29. Tsai H.F., Liu C.S., Leu T.M., Wen F.C., Lin S.J., Liu C.C., Yang D.K., Li C., Hsieh M. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol. Scand. 2004, 109:355-360.
30. Virshup D.M. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell. Biol. 2000, 12:180-185.
31. Xu Y., Chen Y., Zhang P., Jeffrey P.D., Shi Y. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell 2008, 31:873-885.